A. M. Hilton

Details der Publikationsliste

Zeitraum

1992 - 1994

Anzahl

11

Co-Autoren

Phase II study of intermittent continuous infusion of low-dose recombinant interleukin-2 in advanced melanoma and renal cell cancer (1994)

Vlasveld, L. T., Horenblas, S., Hekman, A., Hilton, A. M., Dubbelman, A. C., Melief, C. J. M., ...

Background Previously we described the immunological and clinical effects of prolonged continuous infusion of low dose rIL-2. In this phase II study we explored the therapeutic efficacy of...

Inhibition of antibody-dependent cellular cytotoxicity by artificial immune complexes and pathological sera.

Howat, J M, Moore, M, Hilton, A M, Kimber, I

Detection of immune complexes by inhibition of antibody-dependent cellular cytotoxicity (ADCC) is based on the principle that soluble complexes can compete with target cell-bound antibody for...

C1q binding activity in the sera of patients with chronic lung diseases.

Cooper, K M, Moore, M, Hilton, A M

Sera from patients with chronic lung diseases were tested for the presence of immune complexes (ICs) by the 125I-C1q-binding assay. Contrary to earlier reports, modification of the test system by...

Cutaneous vasculitis and immune complexes in severe bronchiectasis.

Hilton, A M, Hasleton, P S, Bradlow, A, Leahy, B C, Cooper, K M, Moore, M

Four patients with severe bronchiectasis (chronic bronchial suppuration) are described who developed cutaneous lesions associated with exacerbations of their respiratory disease. The skin...

A phase I study of prolonged continuous infusion of low dose recombinant interleukin-2 in melanoma and renal cell cancer. Part I: Clinical aspects.

Vlasveld, L. T., Rankin, E. M., Hekman, A., Rodenhuis, S., Beijnen, J. H., Hilton, A. M., ...

The optimal schedule for recombinant interleukin-2 (rIL-2) administration is unclear. Because the clinical and immunological effects of prolonged continuous exposure to rIL-2 are unknown, we have...